Clinical Trial Update: Antidepressant Incomplete Response Depression

View source ↗

Summary

AstraZeneca-sponsored clinical trial addressing antidepressant-incomplete response in major depressive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Snippet

Sponsor: AstraZeneca | Conditions: Major Depressive Disorder | Status: COMPLETED